G Morana

Summary

Affiliation: Regional Hospital
Country: Italy

Publications

  1. ncbi Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 8:S132-5. 2008
  2. ncbi Cystic tumors of the pancreas
    Giovanni Morana
    Department of Radiology, Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 6:60-71. 2006
  3. ncbi Contrast agents for hepatic MRI
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 7:S24-7. 2007
  4. ncbi Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration
    Giovanni Morana
    Department of Diagnostic Radiology, Ospedale Ca Foncello, Treviso, Italy
    Invest Radiol 46:225-39. 2011
  5. ncbi Staging cancer of the pancreas
    G Morana
    Radiological Department, General Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 10:S137-41. 2010
  6. ncbi Autoimmune pancreatitis: instrumental diagnosis
    Giovanni Morana
    Radiological Department, Hospital Ca' Foncello, Treviso, Italy
    JOP 6:102-7. 2005
  7. ncbi MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison
    Luigi Grazioli
    Department of Radiology, University of Brescia, Brescia, Italy
    J Magn Reson Imaging 17:593-602. 2003
  8. ncbi Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine
    L Grazioli
    Department of Radiology, University of Brescia, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25023 Brescia, Italy
    Radiology 221:731-9. 2001
  9. ncbi Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas
    A Guarise
    Istituto di Radiologia, Ospedale Ca Foncello, Treviso, Italy
    Radiol Med 111:526-38. 2006
  10. ncbi Contrast agents for hepatic magnetic resonance imaging
    Giovanni Morana
    Radiological Department, University of Verona, Verona, Italy
    Top Magn Reson Imaging 13:117-50. 2002

Detail Information

Publications27

  1. ncbi Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 8:S132-5. 2008
    ..Moreover, the continuous follow-up of cancer patients requires an easily available, reliable and cost-effective diagnostic tool for the detection and characterization of FLLs...
  2. ncbi Cystic tumors of the pancreas
    Giovanni Morana
    Department of Radiology, Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 6:60-71. 2006
    ..The management of these patients is complex, and it is important to correlate imaging findings with knowledge of the patient's symptoms and of the natural history and predictors of malignancy in pancreatic cysts...
  3. ncbi Contrast agents for hepatic MRI
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 7:S24-7. 2007
    ..To understand the contrast behaviour after injection of LSCM it is necessary to correlate the contrast enhancement with both the biological and histological findings of FLL...
  4. ncbi Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration
    Giovanni Morana
    Department of Diagnostic Radiology, Ospedale Ca Foncello, Treviso, Italy
    Invest Radiol 46:225-39. 2011
    ..To evaluate hepatobiliary phase magnetic resonance imaging with gadobenate dimeglumine for differentiation of benign hypervascular liver lesions from malignant or high-risk lesions...
  5. ncbi Staging cancer of the pancreas
    G Morana
    Radiological Department, General Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 10:S137-41. 2010
    ..About 60% of tumors originate at the head of the pancreas, 15% in the body, 5% in the tail; 20% are diffuse within the pancreas. This article discusses the imaging and staging of pancreatic cancer...
  6. ncbi Autoimmune pancreatitis: instrumental diagnosis
    Giovanni Morana
    Radiological Department, Hospital Ca' Foncello, Treviso, Italy
    JOP 6:102-7. 2005
  7. ncbi MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison
    Luigi Grazioli
    Department of Radiology, University of Brescia, Brescia, Italy
    J Magn Reson Imaging 17:593-602. 2003
    ..To compare the efficacy of two different MR contrast agents for the detection and diagnosis of focal nodular hyperplasia (FNH)...
  8. ncbi Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine
    L Grazioli
    Department of Radiology, University of Brescia, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25023 Brescia, Italy
    Radiology 221:731-9. 2001
    ..To determine whether gadobenate dimeglumine (Gd-BOPTA) is able to provide morphologic and functional information for characterization of focal nodular hyperplasia (FNH)...
  9. ncbi Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas
    A Guarise
    Istituto di Radiologia, Ospedale Ca Foncello, Treviso, Italy
    Radiol Med 111:526-38. 2006
    ....
  10. ncbi Contrast agents for hepatic magnetic resonance imaging
    Giovanni Morana
    Radiological Department, University of Verona, Verona, Italy
    Top Magn Reson Imaging 13:117-50. 2002
    ..To understand contrast behavior after injection of LSCM, it is necessary to correlate contrast enhancement with the biologic and histologic findings of FLL...
  11. ncbi Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA
    Giovanni Morana
    Department of Radiology, University of Verona, Italy
    Acad Radiol 9:S476-9. 2002
  12. ncbi Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study
    Luigi Grazioli
    Department of Radiology, University of Brescia, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25023 Brescia, Italy
    Radiology 236:166-77. 2005
    ..To prospectively determine the accuracy of differentiating benign focal nodular hyperplasia (FNH) from hepatic adenoma (HA) and liver adenomatosis (LA) by using gadobenate dimeglumine-enhanced magnetic resonance (MR) imaging...
  13. ncbi Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography
    Riccardo Lencioni
    Department of Radiology, University of Pisa, Pisa, Italy
    Dig Dis Sci 50:533-7. 2005
    ..0167). Ferucarbotran-enhanced MR imaging is superior to spiral CT in clinical management of patients with suspected hepatic malignancy...
  14. ncbi Difficult liver lesions in patients with cancer
    G Morana
    Radiological Department, General Hospital C Foncello, Treviso, Italy
    Cancer Imaging 11:S121. 2011
    ..The imaging techniques used for FLLs are discussed in this workshop...
  15. ncbi Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging
    Alessandro Guarise
    Radiological Department, General Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 8:220-8. 2008
    ..No cystic lesion showed changes in morphology and structure. Branch duct IPMNs smaller than 3 cm, without associated filling defects, tend to be stable, making 'watch and wait' management possible...
  16. ncbi Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT
    Carlo Bartolozzi
    Department of Radiology, University of Pisa, Via Roma 67, 56100, Pisa, Italy
    Eur Radiol 14:14-20. 2004
    ..0023) and unenhanced MRI (21 of 44 cases, p=0.0013). MnDPDP-enhanced MRI is superior to unenhanced MRI and spiral CT in the detection of hepatic colorectal metastases...
  17. ncbi Tumors of the spine in children
    Andrea Rossi
    Department of Pediatric Neuroradiology, G Gaslini Children s Hospital, Largo G Gaslini 5, I 16147 Genoa, Italy
    Neuroimaging Clin N Am 17:17-35. 2007
    ..Magnetic resonance imaging provides crucial information regarding the extent, location, and internal structure of the mass, thus critically narrowing the differential diagnosis and guiding surgery...
  18. ncbi Renal artery stenosis evaluation: diagnostic performance of gadobenate dimeglumine-enhanced MR angiography--comparison with DSA
    Gilles Soulez
    Department of Radiology, Centre Hospitalier de l Universite de Montreal, University of Montreal, 1560 Sherbrooke East, Montreal, QC, Canada H2V 2Z2
    Radiology 247:273-85. 2008
    ..1 mmol per kilogram of body weight gadobenate dimeglumine for depiction of significant steno-occlusive disease (> or =51% stenosis) of renal arteries, with digital subtraction angiography (DSA) as reference standard...
  19. ncbi Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial
    Siegfried Thurnher
    Department of Radiology and Nuclear Medicine, Hospital Brothers of St John of God, Grosse Mohrengasse 9, Vienna, Austria A 1020
    AJR Am J Roentgenol 189:1223-37. 2007
    ....
  20. ncbi Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging
    Gunther Schneider
    Department of Diagnostic and Interventional Radiology, University Hospital, Homburg Saar, Germany
    Invest Radiol 42:105-15. 2007
    ..We sought to evaluate gadobenate dimeglumine for the detection and characterization of focal liver lesions in the unenhanced and already pre-enhanced liver...
  21. ncbi The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography
    Henrik S Thomsen
    Department of Diagnostic Radiology, Copenhagen University Hospital, Herlev, Denmark
    Invest Radiol 43:170-8. 2008
    ....
  22. ncbi Whole-body magnetic resonance angiography with blood-pool agents
    Harald Kramer
    Institute for Clinical Radiology, University Hospital Munich, Marchioninstrasse 15, 81377 Munich, Germany
    Eur Radiol 17:B24-9. 2007
    ....
  23. ncbi Diagnostic accuracy of ultrasound dilution access blood flow measurement in detecting stenosis and predicting thrombosis in native forearm arteriovenous fistulae for hemodialysis
    Nicola Tessitore
    Divisione di Nefrologia, Verona, Italy
    Am J Kidney Dis 42:331-41. 2003
    ....
  24. ncbi Current classification and imaging of congenital spinal abnormalities
    Andrea Rossi
    Department of Neuroradiology, G. Gaslini Children's Research Hospital, Genova, Italy
    Semin Roentgenol 41:250-73. 2006
  25. ncbi Prenatal MR imaging of dural sinus malformation: a case report
    Andrea Rossi
    Department of Pediatric Neuroradiology, G Gaslini Children s Hospital, Genoa, Italy
    Prenat Diagn 26:11-6. 2006
    ..To describe prenatal magnetic resonance imaging (MRI) findings of dural sinus malformation (DSM), a very rare, congenital form of dural arteriovenous shunt (DAVS), typically affecting newborns...
  26. ncbi Contrast agents in abdominal imaging: current and future directions
    Gunther Schneider
    Department of Diagnostic and Interventional Radiology, University Hospital of Saarland, Homburg Saar, Germany
    Top Magn Reson Imaging 16:107-24. 2005
    ..The availability of orally administered MR contrast agents has further extended the range of abdominal applications, making MR imaging of the small bowel and the colon established imaging procedures...
  27. ncbi Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse
    Franco Capra
    Department of Biomedical and Surgical Sciences, Internal Medicine A, University of Verona, Verona, Italy
    Dig Dis Sci 50:1535-7. 2005